Clinical Trial Update: Toripalimab in Combination With Chemotherapy as Induced Chemotherapy for Localized Hypopharyngeal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating toripalimab in combination with chemotherapy as induced chemotherapy for localized hypopharyngeal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypopharyngeal Squamous Cell Carcinoma

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Hypopharyngeal Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN